A recent medical trial could help deliver the first daily weight loss pill capable of cutting down obesity as effectively as ...

Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...

Weight loss injections boost the glucagon-like peptide-1 (GLP-1) hormone, which is a naturally produced hormone in the ...

A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, ...

Eli Lilly said its experimental drug, orforglipron, helped people with Type 2 diabetes lower their blood sugar and lose ...

For adults struggling with weight, a weekly injection of tirzepatide offers real hope. Recent findings presented at the ...

Diabetics given the pill called orforglipron lost 16 pounds, or 7.9% of their body weight, over a 40-week period.

A new weight-loss pill taken daily could compete with injections like Ozempic, research suggests. Patients, who all were ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

Pharmaceutical company Eli Lilly’s study of its tablet, orforglipron, has raised hopes of an effective and easy-to-use ...

Orforglipron, a new nonpeptide GLP-1 drug, may provide easier access for the treatment of Type 2 diabetes and obesity without ...

A “game-changing” Ozempic-style daily pill could transform public health in Britain, experts have said. The drug is expected ...